Thrilled to share that our TCR-PREDICT project has been funded by the #ERCCoG program. Huge thanks to the team for their tremendous effort, to INGM, @BellinzonaIrb, and our reviewers for their support. 🙏
The @RGeigerlab at the @BellinzonaIrb used mass spectrometry-based proteomics to profile immune cells isolated from #tumors of patients with liver cancer, which led to the identification of new potential targets for #Immunotherapy.
👉https://t.co/SF1HKhnDjK
@USI_en
Hello #sciencetwitter out there, I call for your help.🙏 Anyone has the sequence of OT145 monoclonal ab, which recognizes the human TRBV7-2 gene (serological Vb6.7)? The mAb got discontinued and cannot find it anywhere. I guess TCRseq made this obsolete... :( Thanks!
Curious about the proteomes of tumor infiltrating immune cells in liver cancer?
Happy to share our new publication released in @cellgenomics.
Proud to be part of the team @RGeigerlab
Excited to share our recent study on immune cell proteomes in liver cancer, now published in @CellGenomics.
https://t.co/IVZTvQqMwn
Proteomics data are now publicly accessible at https://t.co/mkWgulsyeb
A thread about our findings on T cells and macrophages in tumors (1/6)
“Working researchers’ relative silence about such larger societal issues, often under the guise of professionalism, doesn’t make for good science, although it might make for safer scientific careers.” – @DrMaryTBassett https://t.co/xteBH1TUrt